君实生物调整2025年股票期权激励计划授予方案

中访网数据
Yesterday

中访网数据 上海君实生物医药科技股份有限公司董事会薪酬与考核委员会已审核并通过其2025年A股股票期权激励计划的首次授予方案。根据公告,公司对激励对象名单及授予数量进行了调整,原计划首次授予的251名激励对象中,有16人因离职或自愿放弃资格而被剔除,调整后首次授予人数确定为235人。相应的,首次授予的股票期权数量由原计划的2,536.00万份调整为2,515.00万份,激励计划授予的股票期权总数...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10